Independent Director · Inozyme Pharma, Inc. (INZY)

Sarah Bhagat — Inozyme Pharma Director Compensation (2024)

Fiscal year 2024 director compensation for Sarah Bhagat at Inozyme Pharma, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed April 29, 2025 (DEF 14A). Open the filing on EDGAR.

Free

Get Sarah Bhagat’s full pay file as a PDF — free

More than this page: up to 10 years of Sarah’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track Sarah Bhagat and every company like it: Velarion Intel, free for 3 days, no card →

What they were paid

Inozyme Pharma Director Compensation Table · the one fiscal year held
In US dollars, as Inozyme Pharma reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2024$48,766$0$123,200$0$171,966

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Inozyme Pharma, Inc. DEF 14A filed April 29, 2025, accession 0000950170-25-060198, and prior-year filings. Open the filing on EDGAR.

How this page was built: the Inozyme Pharma, Inc. filed document, accession 0000950170-25-060198. Every figure is read from that document and cited to the page and table it appears in. Filed April 29, 2025.

Get the Inozyme Pharma Board Governance Report

$171,966 Sarah Bhagat, FY2024 total director compensation

$500

The free page is the headline figures. The board report is director pay, board composition and committee fees combined into the same kind of document.

Data as of April 29, 2025 · Source: Velarion Executive Compensation Database, deposited on Zenodo (doi:10.5281/zenodo.22283855).

How this board is paid

company policy · FY2024

Inozyme Pharma pays directors a $40,000 cash retainer and $123,200 in Options.

Committees

FY2024 · as the proxy prints them

Audit

The rest of the Inozyme Pharma board

FY2024 · as the company reported each
DirectorRoleFY2024 total
Axel BolteDirector$164,093
Douglas A. TrecoChair of the Board—
Edward MathersIndependent Director$170,950
Erik HarrisIndependent Director$282,286
Lynne SullivanIndependent Director$176,950
Martin EdwardsIndependent Director$185,450
Reinaldo DiazLead Independent Director$191,325
Robert HopfnerIndependent Director$166,950

The full Inozyme Pharma compensation record

free company brief

This page is one director within Inozyme Pharma's record. The company brief lists every named executive and director, each linking to their own page.

Order INZY

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

Board Governance Report